Sanj K Patel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sanj K Patel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanj K Patel. Sanj K Patel is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and President & CEO in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Chairman & CEO in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Latest Insider Trading Transactions of Sanj K Patel
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, KNSA, GEVA, SYRS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 12,002 | 0 | 12,002 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 18,555 | 0 | 18,555 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 26,276 | 0 | 26,276 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 22.89 | 157,658 | 3,608,792 | 157,658 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 1,600 | 2,544 | 325,271 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 20,401 | 32,438 | 326,871 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 4,924 | 7,829 | 347,272 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.07 | 1,137 | 26,231 | 83,336 | 84.5 K to 83.3 K (-1.35 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.06 | 1,600 | 36,896 | 0 | 1.6 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 1,600 | 2,544 | 1,600 | 0 to 1.6 K |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.08 | 23,569 | 543,973 | 84,473 | 108 K to 84.5 K (-21.81 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.00 | 4,528 | 104,144 | 108,042 | 112.6 K to 108 K (-4.02 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.04 | 20,401 | 470,039 | 0 | 20.4 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 20,401 | 32,438 | 20,401 | 0 to 20.4 K |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.00 | 4,924 | 113,252 | 0 | 4.9 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 4,924 | 7,829 | 4,924 | 0 to 4.9 K |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 150,700 | 239,613 | 352,196 | |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 872 | 1,386 | 502,896 | |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.02 | 99,330 | 2,087,917 | 112,570 | 211.9 K to 112.6 K (-46.88 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.02 | 150,700 | 3,167,714 | 0 | 150.7 K to 0 (-100.00 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 150,700 | 239,613 | 150,700 | 0 to 150.7 K |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.00 | 670 | 14,070 | 211,900 | 212.6 K to 211.9 K (-0.32 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.00 | 872 | 18,312 | 0 | 872 to 0 (-100.00 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 872 | 1,386 | 872 | 0 to 872 |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 15.50 | 180,000 | 2,790,000 | 180,000 | |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 15.52 | 180,000 | 2,793,600 | 180,000 | |
Mar 10 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 20.00 | 33,115 | 662,300 | 212,570 | 245.7 K to 212.6 K (-13.48 %) |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 8.83 | 190,000 | 1,677,700 | 190,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 17.92 | 187,000 | 3,351,040 | 187,000 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 30.93 | 125,000 | 3,866,250 | 125,000 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 428,203 | 0 | 1,526,160 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 63,922 | 0 | 0 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 71,967 | 0 | 0 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 428,203 | 0 | 0 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | P | 0.00 | 63,922 | 0 | 63,922 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | C | 0.00 | 135,889 | 0 | 245,685 | 109.8 K to 245.7 K (+123.76 %) |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Patel Sanj K | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | Patel Sanj K | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Patel Sanj K | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Patel Sanj K | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
Sep 29 2015 | BCRX | BIOCRYST PHARMACEU ... | Patel Sanj K | Director | Option Exercise | A | 11.18 | 16,667 | 186,337 | 16,667 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 80.35 | 120,000 | 9,642,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 40.74 | 148,000 | 6,029,520 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 40.32 | 128,000 | 5,160,960 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 23.00 | 136,052 | 3,129,196 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 1.70 | 22,512 | 38,270 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 72,000 | 0 | 0 | 72 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 1,031 | 0 | 72,000 | 73 K to 72 K (-1.41 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 286 | 0 | 0 | 286 to 0 (-100.00 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Grant | A | 0.00 | 72,000 | 0 | 73,031 | 1 K to 73 K (+6,983.51 %) |
Page: 1